RxDoctor Payments Data
★ My doctorsLook up a doctor →

Edwin Ho, MD

Cardiovascular Disease · The Bronx, NYNPI 1467002246

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Abbott at 32.8% of the total. 2025 is the largest year on record at $74,527, more than ten times the $1,092 reported in 2019. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$134,974in general payments, 2019–2025

Across 608 payments — averaging $222.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$44K
  • Medtronic$37K
  • Edwards Lifesciences$25K
  • GE HealthCare$13K
  • Biosense Webster, Inc.$9K
  • Boston Scientific$2K
  • plus $4K from 12 others
$232,441in research payments, 2019–2025

Across 94 payments — averaging $2472.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$225K
  • Medtronic$8K

What the payments were for

  • Consulting fees$55,52541%
  • Speaking & faculty fees$15,55112%
  • Grants$2,4042%
  • Travel & lodging$30,59923%
  • Food & beverage$30,89523%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott71$44,332
Medtronic(2 entities)202$37,167
Edwards Lifesciences255$25,486
GE HealthCare10$13,300
Biosense Webster, Inc.14$8,553
Boston Scientific20$1,701
Artivion, Inc.3$1,205
Philips North America LLC14$1,166
W. L. Gore & Associates, Inc.6$820
Shockwave Medical, Inc4$594
Ancora Heart, Inc.1$190
Abiomed1$142
AstraZeneca1$125
Alnylam Pharmaceuticals Inc.1$91
Novartis2$38
Cardiovascular Systems Inc.1$31
Bridgebio Pharma, Inc.1$17
Croivalve Inc1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$134,974 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024
$72,917
Medicare patients
417
Services billed
798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in The Bronx

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →